# Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sensitivities-to-various-epidermal-growth-factor-receptor-tyrosine-kinase/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eri Banno,Yosuke Togashi,Yu Nakamura,Masato Chiba,Yoshihisa Kobayashi,Hidetoshi Hayashi,Masato Terashima,Marco A. De Velasco,Kazuko Sakai,Yoshihiko Fujita,Tetsuya Mitsudomi,Kazuto Nishio |
| Citations | 89 |
| DOI | 10.1111/cas.12980 |
| Fields | Biochemistry, Genetics and Molecular Biology,Chemistry,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cas.12980 |
| OpenAlex ID | https://openalex.org/W2409577054 |
| PMID | 27240419 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Yu Nakamura](https://scholariq.org/researchers/yu-nakamura/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Quinazolinone synthesis and applications](https://scholariq.org/topics/quinazolinone-synthesis-and-applications/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.